XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 226,823 $ 202,004
Marketable securities available-for-sale 454,702 422,391
Accounts receivables, net of allowance for doubtful accounts of $12,313 and $0 at June 30, 2023 and December 31, 2022, respectively 43,245 145,130
Other receivables 2,108 2,385
Inventories 53,088 59,446
Prepaid expenses and other current assets 17,494 85,629
Total current assets 797,460 916,985
Property and equipment, net 37,442 37,596
Operating lease right-of-use assets 25,366 25,745
Goodwill 2,039 2,006
Restricted cash 210 207
Other assets 73,915 3,311
Total assets 936,432 985,850
Current liabilities:    
Accounts payable 3,246 3,211
Accrued research and development 3,594 4,775
CEPI accrual (Note 6) 0 107,738
Accrued liabilities 33,872 30,719
Other current liabilities 4,150 3,631
Total current liabilities 44,862 150,074
Convertible Notes, net of debt discount of $3,366 and $3,922 at June 30, 2023 and December 31, 2022, respectively (Note 7) 222,134 221,578
Long-term portion of lease liabilities 31,545 32,801
Other long-term liabilities 349 384
CEPI accrual long-term 60,337
Total liabilities 359,227 404,837
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock: $0.001 par value; 5,000 shares authorized at June 30, 2023 and December 31, 2022; zero shares outstanding at June 30, 2023 and December 31, 2022, respectively 0 0
Common stock: $0.001 par value; 278,000 shares authorized at June 30, 2023 and December 31, 2022; 128,779 shares and 127,604 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 129 128
Additional paid-in capital 1,527,544 1,510,518
Accumulated other comprehensive loss (5,372) (5,438)
Accumulated deficit (945,096) (924,195)
Total stockholders’ equity 577,205 581,013
Total liabilities and stockholders’ equity $ 936,432 $ 985,850